false
Catalog
Sleep Medicine: Cutting Edge Insights and Innovati ...
Emerging Data in Hypersomnia and Sleep-Related Mov ...
Emerging Data in Hypersomnia and Sleep-Related Movement Disorders DAmbrosio
Back to course
Pdf Summary
The document provides insights into therapies and innovations related to Sleep Medicine, highlighting Restless Leg Syndrome (RLS) and Idiopathic Hypersomnia (IH). For RLS, it lists common therapies including Gabapentin, Dopaminergic agents, and non-pharmacologic therapy like Tonic Motor Activation (TOMAC), while noting that centrally acting antihistamines are contraindicated as they can worsen symptoms. It discusses novel therapies such as TOMAC, a wearable device stimulating peroneal nerve fibers, which shows promise for RLS cases that do not respond to medication.<br /><br />Further, it explores the relationship between obesity and RLS, referencing studies indicating a correlation between higher Body Mass Index (BMI) and poorer sleep quality. Bariatric surgery has been found to reduce BMI and improve RLS symptoms significantly, with many patients discontinuing RLS medications post-surgery.<br /><br />The document also covers Idiopathic Hypersomnia, describing its prevalence, symptoms, and the types of central hypersomnia. Two significant advancements reported are the development of a validated tool to assess hypersomnia and the FDA approval in 2021 of low sodium oxybate for treating IH, which has demonstrated significant symptom improvement and a similar safety profile to its use in Narcolepsy 1.<br /><br />For treatment approaches, it underscores the importance of considering weight loss in managing RLS due to its association with obesity and encourages use of novel non-pharmacologic treatments. The document also presents an overview of key medications for IH, emphasizing the breakthrough of low sodium oxybate as the first FDA-approved treatment specifically for this condition.<br /><br />Overall, the document suggests advancements in both pharmacological and non-pharmacological approaches for managing Sleep Medicine disorders, focusing on innovative treatments that are currently shaping the therapeutic landscape.
Keywords
Sleep Medicine
Restless Leg Syndrome
Idiopathic Hypersomnia
Gabapentin
Tonic Motor Activation
peroneal nerve fibers
Body Mass Index
bariatric surgery
low sodium oxybate
FDA approval
©
|
American College of Chest Physicians
®
×
Please select your language
1
English